| Pharmaceutical active ingredients: |
| Methdilazine |
| Available forms, composition and doses of Bristaline: |
| N / A |
| Bristaline medical category: |
| Human:AnticholinergicsAntihistamines first-generationPhenothiazines |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| R06AD04 - Methdilazine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Brimstone | Sulfur | Unidentified Pharmaceutical Company |
| Brinolase | Brinase | Unidentified Pharmaceutical Company |
| Briplatin | Cisplatin | Unidentified Pharmaceutical Company |
| Bristab | Furosemide; Hydroflumethiazide | Unidentified Pharmaceutical Company |
| Bristaciclin | Tetracycline | Unidentified Pharmaceutical Company |
| Bristamin | Phenyltoloxamine | Unidentified Pharmaceutical Company |
| Bristuric | Bendroflumethiazide | Unidentified Pharmaceutical Company |
| Bristurin | Furosemide; Hydroflumethiazide | Unidentified Pharmaceutical Company |
| Bristuron | Bendroflumethiazide | Unidentified Pharmaceutical Company |
| Britazepam | Diazepam | Unidentified Pharmaceutical Company |